| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.82 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Love Richard L |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
34,844 |
544,109 |
|
- |
|
| Ignagni Karen |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
34,844 |
66,192 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2014-05-05 |
4 |
AS |
$2.93 |
$35,497 |
D/D |
(12,000) |
608,904 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2014-05-01 |
4 |
AS |
$2.90 |
$29,068 |
D/D |
(10,000) |
812,897 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2014-03-28 |
4 |
S |
$3.40 |
$279,780 |
D/D |
(82,000) |
468,937 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2014-03-25 |
4 |
S |
$3.53 |
$356,126 |
D/D |
(100,000) |
448,619 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2014-03-24 |
4 |
S |
$3.46 |
$208,315 |
D/D |
(60,000) |
1,035,234 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2014-03-21 |
4 |
S |
$3.80 |
$475,431 |
D/D |
(125,000) |
822,897 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2014-03-21 |
4 |
S |
$3.79 |
$548,825 |
D/D |
(145,000) |
2,402,794 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2014-03-21 |
4 |
S |
$3.71 |
$633,384 |
D/D |
(170,000) |
620,904 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2014-03-20 |
4 |
S |
$3.86 |
$965,500 |
D/D |
(250,000) |
2,547,794 |
|
- |
|
| Love Richard L |
Director |
– • – |
2014-03-07 |
4 |
S |
$3.75 |
$150,973 |
D/D |
(40,000) |
509,265 |
|
- |
|
| Telling Fred |
Director |
– • – |
2014-03-07 |
4 |
S |
$3.73 |
$270,522 |
D/D |
(72,095) |
401,170 |
|
- |
|
| Ignagni Karen |
Director |
– • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
31,348 |
31,348 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
550,937 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
366,335 |
|
- |
|
| Singer Jack W |
See Remarks |
• • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
394,199 |
1,095,234 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313,997 |
2,797,794 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
219,000 |
548,619 |
|
- |
|
| Tuckson Reed Vaughn |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
536,662 |
|
- |
|
| Bauer John H |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
564,167 |
|
- |
|
| Telling Fred |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
473,265 |
|
- |
|
| Love Richard L |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
549,265 |
|
- |
|
| Bianco Louis A |
See Remarks |
• – – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
394,199 |
947,897 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
394,199 |
790,904 |
|
- |
|
742 Records found
|
|
Page 10 of 30 |
|
|
